Literature DB >> 1712577

Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin.

C Ramb-Lindhauer1, A Feldmann, M Rotte, C Neumann.   

Abstract

Since it has been hypothesized that atopic dermatitis represents a cellular immune reaction to exogenous aeroallergens, we investigated whether lesional skin contains allergen-specific T-cells and which lymphokines they might secrete. Using phytohaemagglutinin or grass pollen for the cloning procedure, we established a series of T-cell lines from the skin of two patients. When rechallenged with the allergen, three out of 12 dermal lines which had been cloned with the pollen extract and three out of 20 epidermal lines cloned with PHA were found to proliferate specifically. With one exception, allergen-specific lines were CD4+, CD8-, alpha/beta receptor +. The reaction pattern to the single components of the grass allergen extract was assessed with the line UH-D3. Further, the proliferative response to Lolium perennis was inhibited by HLA-DR antibody, indicating its dependence on structures of the MHC class II complex. Only one out of four CD4+ allergen-reactive lines secreted considerable interferon-gamma activity but all secreted interleukin-4. The relative predominance of IL-4 points to a possible role of skin-derived T-cells in the synthesis of IgE. The identification of allergen-specific T-cells in lesional skin of patients with atopic dermatitis is consistent with the hypothesis that their dermatitis represents a T-cell-mediated immune reaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712577     DOI: 10.1007/bf00371611

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  25 in total

1.  Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response.

Authors:  I Lefkovits; H Waldmann
Journal:  Immunol Today       Date:  1984-09

Review 2.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

3.  A study of the role of house dust mite in atopic dermatitis.

Authors:  P G Norris; O Schofield; R D Camp
Journal:  Br J Dermatol       Date:  1988-03       Impact factor: 9.302

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 5.  Pharmacophysiology of atopic dermatitis.

Authors:  J M Hanifin
Journal:  Clin Rev Allergy       Date:  1986-02

Review 6.  Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1?

Authors:  B C Melnik; G Plewig
Journal:  J Am Acad Dermatol       Date:  1989-09       Impact factor: 11.527

7.  Basophils in allergen-induced patch test sites in atopic dermatitis.

Authors:  E B Mitchell; J Crow; M D Chapman; S S Jouhal; F M Pope; T A Platts-Mills
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

Review 8.  Cutaneous basophil hypersensitivity.

Authors:  H F Dvorak
Journal:  J Allergy Clin Immunol       Date:  1976-07       Impact factor: 10.793

9.  Eczematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens.

Authors:  S Reitamo; K Visa; K Kähönen; K Käyhkö; S Stubb; O P Salo
Journal:  Br J Dermatol       Date:  1986-03       Impact factor: 9.302

10.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

View more
  13 in total

Review 1.  T cells in allergic responses to haptens and proteins.

Authors:  M L Kapsenberg; J D Bos; E A Wierenga
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Patch testing for noncontact dermatitis: the atopy patch test for food and inhalants.

Authors:  Andreas Wollenberg; Sandra Vogel
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 3.  Allergen-specific immunotherapy in atopic eczema.

Authors:  Ulf Darsow; Ingeborg Forer; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

Review 4.  [Atopic patch test. Atopic eczema and allergy].

Authors:  U Darsow; J Ring
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

5.  Imbalance of CD4+CD29+ and CD4+CD45RA+ T-helper cell subsets in peripheral blood of patients with severe atopic dermatitis.

Authors:  K Jung; A Bittrich; V Klimmek; H Schubert
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

6.  Comparative analysis of the frequency of house dust mite specific and nonspecific Th1 and Th2 cells in skin lesions and peripheral blood of patients with atopic dermatitis.

Authors:  C Neumann; C Gutgesell; F Fliegert; R Bonifer; F Herrmann
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

7.  Different growth factor requirements for human Th2 cells may reflect in vivo induced anergy.

Authors:  F C Van Reijsen; O L Wijburg; M Gebhardt; A G Van Ieperen-Van Dijk; S Betz; E M Poellabauer; T Thepen; C A Bruijnzeel-Koomen; G C Mudde
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

8.  Relationship between facilitated allergen presentation and the presence of allergen-specific IgE in serum of atopic patients.

Authors:  F L van der Heijden; R J van Neerven; M L Kapsenberg
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

9.  Interleukin 5 expressing allergen-specific T-lymphocytes in patients with house dust mite sensitization: analysis at a clonal level.

Authors:  R Bonifer; C Neumann; S Meuer; G Schulze; F Herrmann
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

10.  Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects.

Authors:  C F Wahlgren; M Tengvall Linder; O Hägermark; A Scheynius
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.